Pharma Dividends Face Their Real Test on September 29
J&J, Pfizer, and Merck head into New York with 16 days before 232 pharma tariffs expand. Here is what income investors need to know.
Author: The Trading Report
395 Breached Orgs Show AI Attacks Are Here. Can CRWD, PANW, and ZS Sell the Fix?
The GreyNoise PaperCut campaign ends the threat debate. Can budgets move?
Elon’s “Supercurrency” Is Already Shaking up the Market… Here’s What’s Next
A note from our friends at Stocks to Trade(ad) In the wake of the biggest IPO in history, Elon Musk…
Brent Above $100 With Iran Talks Monday. Here Is How to Trade It.
Monday’s Oman meeting between Gulf and Iranian ministers puts every energy position on a hair trigger, and the IEA just made the demand side of the equation far worse.
Copper at $6.45 After the Record Drop. Here Is What Traders Watch Monday.
The White House still has no decision on refined copper tariffs, and that uncertainty is now the only price that matters.
Almost Gone
September 11, 2026 Bonus Content: Fortinet’s Firewall Crown Just Got an AI Engine A note from our friends at Profits…
Enbridge Is Spending $2.55 Billion on a Pipeline. Will the Dividend Survive?
The Pony Express deal grows Enbridge’s U.S. crude network, but income investors need to know how the company is paying for it.
Will Your Wealth Survive the MAR-A-LAGO RESET?
September 10, 2026 Bonus Content: Bessent Told Yen Shorts to Quit. How to Trade What’s Next. A note from our…
At 6.76%, the Mortgage Market Is Frozen. Here’s Who Pays and Who Profits.
Rising rates have stopped the housing market from clearing. The more important question is which housing-linked holdings are already priced for that reality.
Silver at $67 Is Up 63% in a Year and Still Pulling Away From Gold
A weak dollar, the U.S.-Iran conflict, and industrial demand are doing three different jobs at once, and traders need to decide which one they trust.